Advertisement

Child's Nervous System

, Volume 34, Issue 5, pp 893–900 | Cite as

Early vagal nerve stimulator implantation in children: personal experience and review of the literature

  • Jehuda Soleman
  • Corine Knorr
  • Alexandre N. Datta
  • Susi Strozzi
  • Gian Paolo Ramelli
  • Luigi Mariani
  • Raphael Guzman
Original Paper

Abstract

Aim

Data concerning the benefit of vagal nerve stimulation (VNS) in children under the age of 12 years is sparse. It was shown that reduction of seizure frequency and duration at an early age could lead to better psychomotor development. We therefore compare the outcome between early (≤ 5 years of age) and late (> 5 years of age) implantation of VNS in children.

Methods

This study is a prospective review of patients analyzing primarily the reduction of seizure frequency and secondarily epilepsy outcome assessed by the McHugh and Engel classification, reduction of antiepileptic drugs (AED), psychomotor development measured by the Vineland Adaptive Behavior Scale (VABS), and quality of life using the caregiver impression (CGI) scale. Mean follow-up time was 36 and 31 months in the early and late group, respectively.

Results

Out of 12 consecutive VNS implantations for therapy refractory epilepsy, 5 were early implantations and 7 late implantations. Reduction of seizure frequency, McHugh and Engel classification, quality of life, psychomotor development and reduction of AED were comparable in both groups. One patient in the late group suffered from a postoperative infection resulting in explanation of the VNS device and re-implantation on the opposite side, while mortality rate was 0%.

Conclusions

VNS seems to be a safe and feasible therapy in children even under the age of 5 years. Responder rate, quality of life, and psychomotor development do not seem to be influenced by the child’s age at implantation; however, larger studies analyzing the outcome of early VNS implantation are warranted.

Keywords

Epilepsy Vagal nerve stimulator Vineland Adaptive Behavior Scale Drug-resistant epilepsy Psychomotor development Quality of life 

Notes

Acknowledgments

We would like to thank Mrs. Marianne Schulz for her editorial help.

Compliance with ethical standards

The study protocol was approved by the local ethics committee (EKNZ, Basel, Switzerland).

Conflict of interest

The authors have no disclosures and no conflict of interest.

References

  1. 1.
    Elliott RE, Rodgers SD, Bassani L, Morsi A, Geller EB, Carlson C, Devinsky O, Doyle WK (2011) Vagus nerve stimulation for children with treatment-resistant epilepsy: a consecutive series of 141 cases. J Neurosurg Pediatr 7(5):491–500.  https://doi.org/10.3171/2011.2.PEDS10505 CrossRefPubMedGoogle Scholar
  2. 2.
    Healy S, Lang J, Te Water Naude J, Gibbon F, Leach P (2013) Vagal nerve stimulation in children under 12 years old with medically intractable epilepsy. Childs Nerv Syst 29(11):2095–2099.  https://doi.org/10.1007/s00381-013-2143-3 CrossRefPubMedGoogle Scholar
  3. 3.
    Terra VC, Furlanetti LL, Nunes AA, Thome U, Nisyiama MA, Sakamoto AC, Machado HR (2014) Vagus nerve stimulation in pediatric patients: is it really worthwhile? Epilepsy Behav 31:329–333.  https://doi.org/10.1016/j.yebeh.2013.10.011 CrossRefPubMedGoogle Scholar
  4. 4.
    Berg AT, Rychlik K, Levy SR, Testa FM (2014) Complete remission of childhood-onset epilepsy: stability and prediction over two decades. Brain 137(12):3213–3222.  https://doi.org/10.1093/brain/awu294 CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Alexopoulos AV, Kotagal P, Loddenkemper T, Hammel J, Bingaman WE (2006) Long-term results with vagus nerve stimulation in children with pharmacoresistant epilepsy. Seizure 15(7):491–503.  https://doi.org/10.1016/j.seizure.2006.06.002 CrossRefPubMedGoogle Scholar
  6. 6.
    Benifla M, Rutka JT, Logan W, Donner EJ (2006) Vagal nerve stimulation for refractory epilepsy in children: indications and experience at The Hospital for Sick Children. Childs Nerv Syst 22(8):1018–1026.  https://doi.org/10.1007/s00381-006-0123-6 CrossRefPubMedGoogle Scholar
  7. 7.
    Coykendall DS, Gauderer MW, Blouin RR, Morales A (2010) Vagus nerve stimulation for the management of seizures in children: an 8-year experience. J Pediatr Surg 45(7):1479–1483.  https://doi.org/10.1016/j.jpedsurg.2010.02.066 CrossRefPubMedGoogle Scholar
  8. 8.
    Hauptman JS, Mathern GW (2012) Vagal nerve stimulation for pharmacoresistant epilepsy in children. Surg Neurol Int 3(Suppl 4):S269–S274.  https://doi.org/10.4103/2152-7806.103017 PubMedPubMedCentralGoogle Scholar
  9. 9.
    Menascu S, Kremer U, Schiller Y, Blatt I, Watemberg N, Boxer M, Goldberg H, Korn-Lubetzki I, Steinberg M, Ben-Zeev B (2013) The Israeli retrospective multicenter open-label study evaluating vagus nerve stimulation efficacy in children and adults. Isr Med Assoc J 15(11):673–677PubMedGoogle Scholar
  10. 10.
    Yu C, Ramgopal S, Libenson M, Abdelmoumen I, Powell C, Remy K, Madsen JR, Rotenberg A, Loddenkemper T (2014) Outcomes of vagal nerve stimulation in a pediatric population: a single center experience. Seizure 23(2):105–111.  https://doi.org/10.1016/j.seizure.2013.10.002 CrossRefPubMedGoogle Scholar
  11. 11.
    Thompson EM, Wozniak SE, Roberts CM, Kao A, Anderson VC, Selden NR (2012) Vagus nerve stimulation for partial and generalized epilepsy from infancy to adolescence. J Neurosurg Pediatr 10(3):200–205.  https://doi.org/10.3171/2012.5.PEDS11489 CrossRefPubMedGoogle Scholar
  12. 12.
    Cersosimo RO, Bartuluchi M, Fortini S, Soraru A, Pomata H, Caraballo RH (2011) Vagus nerve stimulation: effectiveness and tolerability in 64 paediatric patients with refractory epilepsies. Epileptic Disord 13(4):382–388.  https://doi.org/10.1684/epd.2011.0479 PubMedGoogle Scholar
  13. 13.
    Ryzi M, Brazdil M, Novak Z, Chrastina J, Oslejskova H, Rektor I, Kuba R (2013) Long-term vagus nerve stimulation in children with focal epilepsy. Acta Neurol Scand 127(5):316–322.  https://doi.org/10.1111/ane.12009 CrossRefPubMedGoogle Scholar
  14. 14.
    Helmers SL, Duh MS, Guerin A, Sarda SP, Samuelson TM, Bunker MT, Olin BD, Jackson SD, Faught E (2012) Clinical outcomes, quality of life, and costs associated with implantation of vagus nerve stimulation therapy in pediatric patients with drug-resistant epilepsy. Eur J Paediatr Neurol 16(5):449–458.  https://doi.org/10.1016/j.ejpn.2012.01.001 CrossRefPubMedGoogle Scholar
  15. 15.
    Zamponi N, Rychlicki F, Corpaci L, Cesaroni E, Trignani R (2008) Vagus nerve stimulation (VNS) is effective in treating catastrophic 1 epilepsy in very young children. Neurosurg Rev 31(3):291–297.  https://doi.org/10.1007/s10143-008-0134-8 CrossRefPubMedGoogle Scholar
  16. 16.
    Colicchio G, Policicchio D, Barbati G, Cesaroni E, Fuggetta F, Meglio M, Papacci F, Rychlicki F, Scerrati M, Zamponi N (2010) Vagal nerve stimulation for drug-resistant epilepsies in different age, aetiology and duration. Childs Nerv Syst 26(6):811–819.  https://doi.org/10.1007/s00381-009-1069-2 CrossRefPubMedGoogle Scholar
  17. 17.
    Sparrow SS BD, Cicchetti DV, Doll EA. (ed) (1984) Vineland adaptive behavior scales: interview edition, expanded form manual. 2nd ed.Circle Pines American Guidance Service, MinnGoogle Scholar
  18. 18.
    Orosz I, McCormick D, Zamponi N, Varadkar S, Feucht M, Parain D, Griens R, Vallee L, Boon P, Rittey C, Jayewardene AK, Bunker M, Arzimanoglou A, Lagae L (2014) Vagus nerve stimulation for drug-resistant epilepsy: a European long-term study up to 24 months in 347 children. Epilepsia 55(10):1576–1584.  https://doi.org/10.1111/epi.12762 CrossRefPubMedGoogle Scholar
  19. 19.
    Bodin E, Le Moing AG, Bourel-Ponchel E, Querne L, Toussaint P, Berquin P (2016) Vagus nerve stimulation in the treatment of drug-resistant epilepsy in 29 children. Eur J Paediatr Neurol 20(3):346–351.  https://doi.org/10.1016/j.ejpn.2016.01.011 CrossRefPubMedGoogle Scholar
  20. 20.
    Majoie HJ, Berfelo MW, Aldenkamp AP, Evers SM, Kessels AG, Renier WO (2001) Vagus nerve stimulation in children with therapy-resistant epilepsy diagnosed as Lennox-Gastaut syndrome: clinical results, neuropsychological effects, and cost-effectiveness. J Clin Neurophysiol 18(5):419–428.  https://doi.org/10.1097/00004691-200109000-00006 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2017

Authors and Affiliations

  • Jehuda Soleman
    • 1
    • 2
  • Corine Knorr
    • 1
    • 2
  • Alexandre N. Datta
    • 3
  • Susi Strozzi
    • 4
  • Gian Paolo Ramelli
    • 5
  • Luigi Mariani
    • 1
    • 2
  • Raphael Guzman
    • 1
    • 2
  1. 1.Department of NeurosurgeryUniversity Hospital of BaselBaselSwitzerland
  2. 2.Division of Pediatric NeurosurgeryChildren’s University Hospital of Basel (UKBB)BaselSwitzerland
  3. 3.Department of Pediatric NeurologyChildren’s University Hospital of Basel (UKBB)BaselSwitzerland
  4. 4.Department of Pediatric NeurologyUniversity Hospital of BernBernSwitzerland
  5. 5.Department of Pediatric NeurologyChildren’s Hospital of BellinzonaBellinzonaSwitzerland

Personalised recommendations